Navigation Links
Rockefeller University's Center for Clinical and Translational Science funds pilot studies
Date:1/7/2008

The Rockefeller University Center for Clinical and Translational Science (CCTS) has announced the recipients of its 2008 Pilot Project grants. Eight Rockefeller researchers will each receive $25,000 from the center to fund early studies in translational science that, if successful, might lead to clinical trials. The CCTS and the grant program are in their second year, established through funds from a Clinical and Translational Science Award the university received from the National Center for Research Resources of the National Institutes of Health. In its first year, the program provided $165,000 for nine clinical studies.

The centers administration selected the 2008 pilot projects from among proposals submitted in the fall. The recipients are:

  • Marina Caskey, an instructor in clinical investigation, to compare the efficacy of poly IC and Ampligen as adjuvants for an HIV vaccine targeted at DEC-205, an antigen receptor on dendritic cells.

  • Delivette Castor, instructor in clinical investigation, to apply demographic, psychosocial, sexual and drug use history and other data gathered from 280 men who have sex with men to examine the roles of these factors in the risk of HIV-1 infection and transmitted drug resistance.

  • Mouquet Hugo, postdoctoral fellow in Michel Nussenzweigs Laboratory of Molecular Immunology, to elucidate the etiology of Pemphigus vulgaris, a life-threatening autoimmune disease affecting skin and mucosa, by comparing repertoires of autoreactive and polyreactive B cells in patients with the disease to those of healthy volunteers.

  • Igor Kravets, instructor in clinical investigation, to examine the mechanism of action of disulfiram, a drug commonly used to treat chronic alcoholism, with regard to cocaine addiction.

  • Jan Lunemann, postdoctoral fellow in Christian Mnzs Laboratory of Viral Immunobiology, to test the hypothesis that a cause of multiple sclerosis is an aberrant response of the central nervous system to the Epstein Barr virus on the level of virus-infected B cells.

  • Lisa Neff, instructor in clinical investigation, to test the hypothesis that the Dietary Approaches to Stop Hypertension diet and the low glycemic index diet improve insulin sensitivity in patients with insulin resistance and/or metabolic syndrome.

  • Swaroop Pendyala, instructor in clinical investigation, to determine if significant weight loss achieved by dieting decreases chronic inflammation in the colorectal epithelium and reduces fecal calprotectin levels.

  • Alexander Ploss, postdoctoral associate in Charles Rices Laboratory of Virology and Infectious Disease, to generate patient-specific human hepatocytes as a renewable source for primary liver tissue.


'/>"/>

Contact: Joseph Bonner
bonnerj@rockefeller.edu
212-327-8998
Rockefeller University
Source:Eurekalert

Related medicine news :

1. National Patient Advocate Foundation Hails Senator Rockefeller for Introducing Bill Protecting Patient Access to Health Coverage
2. Columbia Center for Childrens Environmental Health receives NIEHS grant to study asthma
3. Parkway Clinical Laboratories Expands Management Team to Support a National Growth Strategy Centered on Oral Fluid Drug Screening
4. Susan G. Komen for the Cure, Ryan Community Health Centers, Breast Cancer Survivors Call on New York State to Expand Breast Cancer Screening, Treatment Programs
5. Language centers revealed, brain surgery refined with new mapping
6. Brown named Center of Excellence in Geriatric Medicine and Training
7. American College of Physicians receives grant to study cost of patient-centered medical home
8. Americas Blood Centers Thanks Donors During Celebration of National Blood Donor Month
9. Grubb & Ellis Healthcare REIT Acquires Chesterfield Rehabilitation Center in Chesterfield, Missouri in a Joint Venture with Duke Realty
10. Fitworks West Chester Mega-Center Now Open
11. National Drug Intelligence Center Releases 2008 National Methamphetamine Threat Assessment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Healthcare Research & Analytics® ... the fight against cancer, has produced a seminal study that asked cancer survivors ... top-line findings in a webinar, Defining Compassionate Care Through the Voices of Patients ...
(Date:2/23/2017)... ... (PRWEB) February 23, 2017 -- ... to come together to combine its favorite springtime pastime – ... fruit – apples! To celebrate National Nutrition Month, the U.S. ... Madness” bracket tournament – a five-week, five-round online competition spotlighting ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Top cosmetic ... Smiling Patriot program today with a new Indiegogo campaign . Individuals are ... homeless veterans in the Los Angeles area, either as a participating patient or through ...
(Date:2/23/2017)... , ... February 23, 2017 , ... HealthPostures, the desk ... an expert sit stand solutions representative to the Minneapolis Home and Garden Show which ... the event that is garnering national attention is the Minneapolis Convention Center. , ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Carlos ... problems. He has also continued to spiritually evolve, which is the purpose of everyone ... “ Our Spiritual Truths ” (published by Balboa Press) attempts to guide readers to ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... York , February 23, 2017 ... Holter Monitor Market are GE Healthcare, Koninklijke Philips N.V., ... about 48% in the global market in 2015. Strong ... two key factors assessed to be aiding these players ... Research states that the players in the global market ...
(Date:2/23/2017)... February 23, 2017 Tillotts Pharma ... Berlin office was opened in ... . The portfolio includes Entocort ® for the ... treatment of ulcerative colitis, and VistaPrep ® for ... Swiss specialty pharmaceutical company focused on the treatment of ...
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, ... ) today announced its year end 2016 financial results.  ... January 2017, OncoGenex, and Achieve Life Science, Inc., a privately ... into a definitive merger agreement under which OncoGenex will ... the proposed merger, Achieve,s stockholders are expected to own ...
Breaking Medicine Technology: